why Healthpeak Properties Inc. [PEAK] is a Good Choice for Investors After New Price Target of $37.22

Related

Healthpeak Properties Inc. [NYSE: PEAK] closed the trading session at $34.24 on 04/28/22. The day’s price range saw the stock hit a low of $33.47, while the highest price level was $34.345. The company report on April 5, 2022 that Healthpeak Properties to Report First Quarter Financial Results and Host Conference Call/Webcast.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here. .

Sponsored

Healthpeak Properties, Inc. (NYSE: PEAK) is scheduled to report its first quarter 2022 financial results after the close of trading on the New York Stock Exchange on Tuesday, May 3, 2022. Healthpeak will host a conference call and webcast on Wednesday, May 4, 2022, at 9:00 a.m. Mountain Time (11:00 a.m. Eastern Time) in order to review its financial performance and operating results for the first quarter ended March 31, 2022.

The dial-in number for the conference call is (888) 317-6003 (U.S.) or (412) 317-6061 (international). The conference ID number is 10165073. You may also access the conference call via webcast at https://ir.healthpeak.com/webcasts. An archive of the webcast will be available on Healthpeak’s website through May 4, 2023, and a telephonic replay can be accessed through May 18, 2022, by calling (877) 344-7529 (U.S.) or (412) 317-0088 (international) and entering conference ID number 4992902.

The stocks have a year to date performance of -5.13 percent and weekly performance of -3.28 percent. The stock has been moved at -3.98 percent over the last six months. The stock has performed -2.98 percent around the most recent 30 days and changed -0.29 percent over the most recent 3-months.

If compared to the average trading volume of 3.85M shares, PEAK reached to a volume of 3038950 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here’s what leading stock market gurus have to say about Healthpeak Properties Inc. [PEAK]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for PEAK shares is $37.22 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on PEAK stock is a recommendation set at 2.20. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Credit Suisse have made an estimate for Healthpeak Properties Inc. shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on February 01, 2022. While these analysts kept the previous recommendation, JP Morgan raised their target price from $38 to $40. The new note on the price target was released on December 20, 2021, representing the official price target for Healthpeak Properties Inc. stock.

The Average True Range (ATR) for Healthpeak Properties Inc. is set at 0.67, with the Price to Sales ratio for PEAK stock in the period of the last 12 months amounting to 9.98. The Price to Book ratio for the last quarter was 2.83, with the Price to Cash per share for the same quarter was set at 0.29.

PEAK stock trade performance evaluation

Healthpeak Properties Inc. [PEAK] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -3.28. With this latest performance, PEAK shares dropped by -2.98% in over the last four-week period, additionally sinking by -3.98% over the last 6 months – not to mention a rise of 1.09% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for PEAK stock in for the last two-week period is set at 48.55, with the RSI for the last a single of trading hit 45.18, and the three-weeks RSI is set at 50.17 for Healthpeak Properties Inc. [PEAK]. The present Moving Average for the last 50 days of trading for this stock 33.48, while it was recorded at 34.18 for the last single week of trading, and 34.57 for the last 200 days.

Earnings per share (EPS) analysis for Healthpeak Properties Inc. [PEAK] stock

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for PEAK. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Healthpeak Properties Inc. go to 2.90%.

Healthpeak Properties Inc. [PEAK]: Insider Ownership positions

There are presently around $17,734 million, or 98.40% of PEAK stock, in the hands of institutional investors. The top three institutional holders of PEAK stocks are: VANGUARD GROUP INC with ownership of 86,061,246, which is approximately 0.368% of the company’s market cap and around 0.20% of the total institutional ownership; COHEN & STEERS, INC., holding 69,789,876 shares of the stock with an approximate value of $2.39 billion in PEAK stocks shares; and BLACKROCK INC., currently with $1.96 billion in PEAK stock with ownership of nearly 4.485% of the company’s market capitalization.

290 institutional holders increased their position in Healthpeak Properties Inc. [NYSE:PEAK] by around 28,427,942 shares. Additionally, 266 investors decreased positions by around 16,432,226 shares, while 105 investors held positions by with 473,059,601 shares. The mentioned changes placed institutional holdings at 517,919,769 shares, according to the latest SEC report filing. PEAK stock had 82 new institutional investments in for a total of 4,598,188 shares, while 54 institutional investors sold positions of 1,760,162 shares during the same period.